The Center for Business Intelligence (CBI) will hold the Clinical Trial Registries and Results Databases conference on April 24 - 25, 2006 at the Sheraton National in Arlington, VA.

CBI is pleased to announce that Theresa Toigo, Director, Office of Special Health Issues, Food and Drug Administration will provide an "Update on the FDAMA 113 Methods of Clinical Registration and Enforcement" at the conference in April. This conference addresses the increasing public pressure for pharmaceutical manufacturers to disclose more clinical trial information. Join Theresa Toigo and many other industry experts as they discuss two separate, but related areas in which more disclosure is desired: transparent registration of clinical trial protocols at, or prior to inception and publication of all clinical trial results, both positive and negative. Attend CBI's Clinical Trial Registries and Results Databases conference to learn how the industry responded, and how today most companies have either created their own company websites to disclose this information, or are participating in established registries and/or results databases.

This conference educates attendees on:

• A brief history of registries and results databases
• The important issue of transparency
• Several types of clinical trial registries and results databases available
• Different stakeholder perspectives on clinical trial registries and results databases
• How using registries and results databases can increase patient awareness and recruitment
• And more!

Outstanding support provided by: PharmaVOICE, Thomson Centerwatch, International Journal of Pharmaceutical Medicine and Clinical Drug Investigation.

For more information on this event or to register, contact CBI Registration at 800-817-8601, Fax 781-939-2490, visit http://www.cbinet.com/show_conference.cfm?confcode=HB635 or e-mail cbireg@cbinet.com.